Supplementary Figure 4 from Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma

MLA

Kenneth C. Anderson, et al. Supplementary Figure 4 from Dual Inhibition of Canonical and Noncanonical NF-ΚB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22455918.v1.

APA

Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Yu-Tzu Tai, Ruben D. Carrasco, Jeffrey Meshulam, Jie Zhang, Hiroto Ohguchi, Jiro Minami, Yiguo Hu, Diana Cirstea, Güllü Gorgun, Sun-Young Kong, Kathryn Bobb, Naoya Mimura, & Claire Fabre. (2023). Supplementary Figure 4 from Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma. https://doi.org/10.1158/1078-0432.22455918.v1

Chicago

Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Yu-Tzu Tai, Ruben D. Carrasco, Jeffrey Meshulam, Jie Zhang, et al. 2023. “Supplementary Figure 4 from Dual Inhibition of Canonical and Noncanonical NF-ΚB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma,” March. doi:10.1158/1078-0432.22455918.v1.